IntelliRay
Latest round
- Series C
Last raised
- Jun 2024
Total raised
- $67M
Investors
- 6
About IntelliRay
Founded in 2018 and based in Shenyang, China, IntelliRay is a medical company that focuses on the research and development of oncology radiotherapy technologies, products, and solutions. The company is the wholly owned subsidiary of Neusoft Medical. IntelliRay was recognized as the National High-tech Enterprise. The company has more than 40 patents. It cooperated with In Sun Yat-sen University Cancer Center, China Electronics Technology Group Corporation, Southern Medical University, etc. The company has 37 service teams and 21 spare parts centers at home and abroad. Shaojie Wu, the chairman of the company, used to work in Shanghai Neusoft Medical Equipment and other companies. IntelliRay mainly provides oncology radiotherapy solutions based on artificial intelligence, cloud computing, and other technologies. Its products include NeuRT Aurora Smart Radiotherapy Platforms, NeuOIS Polaris Aurora Oncology Information Systems, and NeuOIS Cloud Aurora Remote Radiotherapy Platforms. The NeuRT Aurora Smart Radiotherapy Platforms are equipped with fiber-optic distributed real-time control systems (RTCS) and iCBCT diagnostic-grade image guidance systems, which adopt Spiral Volume Modulation Therapy (SVMAT) technology. Products and solutions mainly serve oncology patients. The company generates revenue by providing oncology radiotherapy products and solutions.
Who invested in IntelliRay
6 investors across 3 rounds
See all investors in IntelliRay
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IntelliRay
Who invested in IntelliRay?
IntelliRay has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IntelliRay raised?
IntelliRay has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did IntelliRay last raise money?
IntelliRay's most recent round on record is a Series C, in Jun 2024.
What does IntelliRay do?
Founded in 2018 and based in Shenyang, China, IntelliRay is a medical company that focuses on the research and development of oncology radiotherapy technologies, products, and solutions.
Where is IntelliRay headquartered?
IntelliRay is headquartered in Shenyang, China.
Which VCs invest in companies like IntelliRay?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at IntelliRay's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like IntelliRay? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.